These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 50132
1. Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells. Lee T, Karon M, Monparler RL. Cancer Res; 1975 Sep; 35(9):2506-10. PubMed ID: 50132 [Abstract] [Full Text] [Related]
5. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells. Lauzon GJ, Paran JH, Paterson AR. Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174 [Abstract] [Full Text] [Related]
6. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine. Bhalla K, Nayak R, Grant S. Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869 [Abstract] [Full Text] [Related]
7. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells. White JC, Capizzi RL. Cancer Res; 1991 May 15; 51(10):2559-65. PubMed ID: 2021937 [Abstract] [Full Text] [Related]
8. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. Veselý J, Cihák A. Cancer Res; 1977 Oct 15; 37(10):3684-9. PubMed ID: 71199 [Abstract] [Full Text] [Related]
9. Influence of tetrahydrouridine on the phosphorylation of 1-beta-D-arabinofuranosyl-cytosine (ara-C) by enzymes from solid tumors in vitro. Furner RL, Mellett LB, Herren TC. J Pharmacol Exp Ther; 1975 Jul 15; 194(1):103-10. PubMed ID: 1057009 [Abstract] [Full Text] [Related]
10. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine. Li ZR, Campbell J, Rustum YM. Cancer Treat Rep; 1983 Jun 15; 67(6):547-54. PubMed ID: 6190558 [Abstract] [Full Text] [Related]
11. Mutagenicity of 5-azacytidine and related nucleosides in C3H/10T 1/2 clone 8 and V79 cells. Landolph JR, Jones PA. Cancer Res; 1982 Mar 15; 42(3):817-23. PubMed ID: 6174215 [Abstract] [Full Text] [Related]
12. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response. Riva CM, Rustum YM. Cancer Res; 1985 Dec 15; 45(12 Pt 1):6244-9. PubMed ID: 2998596 [Abstract] [Full Text] [Related]
13. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines. Kees UR, Ford J, Dawson VM, Piall E, Aherne GW. Cancer Res; 1989 Jun 01; 49(11):3015-9. PubMed ID: 2720661 [Abstract] [Full Text] [Related]
16. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia. Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW. Cancer Res; 1984 Feb 01; 44(2):825-30. PubMed ID: 6692380 [Abstract] [Full Text] [Related]
19. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH. Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808 [Abstract] [Full Text] [Related]
20. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4). Townsend A, Leclerc JM, Dutschman G, Cooney D, Cheng YC. Cancer Res; 1985 Aug 15; 45(8):3522-8. PubMed ID: 2410096 [Abstract] [Full Text] [Related] Page: [Next] [New Search]